Quantification of desferrioxamine in blood plasma by inductively coupled plasma atomic emission spectrometry.
A sensitive method, inductively coupled plasma atomic emission spectroscopy, is used to measure desferrioxamine in blood plasma. The desferrioxamine is transformed into its iron chelate, ferrioxamine, which is extracted into benzyl alcohol, then re-extracted into HCl (0.5 mol/L), which is used as the sample for the spectroscopy. For a 0.5-mL plasma sample, the detection limit (1 microgram/mL) suffices for following the concentration of desferrioxamine in plasma after its subcutaneous or intramuscular injection (40 mg per kg of body weight). Neither blood pigments nor trace metals interfere.
D003124:Colorimetry; D003676:Deferoxamine / Q000097:blood* / Q000652:urine; D006801:Humans; D007202:Indicators and Reagents; D007676:Kidney Failure, Chronic / Q000097:blood; D011786:Quality Control; D013057:Spectrum Analysis / Q000379:methods; D013789:Thalassemia / Q000097:blood
D007202:Indicators and Reagents; D003676:Deferoxamine